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Abstract
In recent years, the cancer research and care community has been more attuned to health equity, increasingly
pursuing coordinated and comprehensive action to achieve equitable health outcomes. In addition to its support
of a joint research agenda for health disparities in 2017, the National Cancer Institute (NCI) has demonstrated its
commitment to addressing health inequities with its 2012 requirement for cancer centers to deﬁne and address
the needs of a local ‘‘catchment area’’ and the 2016 mandate for Community Outreach and Engagement (COE).
With several years of experience with the COE requirements, there is an opportunity to reﬂect on the experience
to-date and identify opportunities to bolster the impact of COE on equitable cancer outcomes for the future. To
do so, the Bristol Myers Squibb Foundation (BMSF) hosted a special convening and listening session in April 2019.
The session agenda was cocreated by BMSF and NCI leaders and staff. It brought together 41 individuals, including representatives from the NCI Cancer Centers Program, Division of Cancer Control and Population Health and
Center to Reduce Cancer Health Disparities, 22 NCI-designated, emerging or afﬁliated comprehensive cancer
centers, and the broader cancer community. This article captures key themes from that meeting, including an
overview of current COE efforts, with a deeper look at how four cancer centers are embedding health equity
and COE efforts into their institutions and work, and the successes and challenges they have encountered.
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to achieve equitable health outcomes. In addition to
its support of a joint research agenda for health disparities in 2017, the National Cancer Institute (NCI) has
demonstrated its commitment to addressing health
inequities with its 2012 requirement for cancer centers
to deﬁne and address the needs of a local ‘‘catchment
area’’ (CA) and the 2016 mandate for Community Outreach and Engagement (COE).1,2

A Convening on Health Equity Efforts at Cancer
Centers and the Evolving National Cancer
Institute’s Community Outreach
and Engagement Requirements for Designated
Comprehensive Cancer Centers
In recent years, the cancer research and care community has been more attuned to health equity, increasingly pursuing coordinated and comprehensive action
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With several years of experience with the COE requirements, there is an opportunity to reﬂect on the experience to-date and identify opportunities to bolster
the impact of COE on equitable cancer outcomes for
the future. To do so, the Bristol Myers Squibb Foundation (BMSF) hosted a special convening and listening
session in April 2019. The session agenda was cocreated by BMSF and NCI leaders and staff. It brought together 41 individuals, including representatives from
the NCI Cancer Centers Program, Division of Cancer
Control and Population Health and Center to Reduce
Cancer Health Disparities, 22 NCI-designated, emerging, or afﬁliated comprehensive cancer centers (CCC),
and the broader cancer community.
This article captures key themes from that meeting,
including an overview of current COE efforts, with a
deeper look at how four cancer centers are embedding
health equity and COE efforts into their institutions
and work, and the successes and challenges they have
encountered.

FIG. 1.
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Current Community Outreach and Engagement
Activity at Cancer Centers
Inequitable health outcomes are the result of historical
and structural issues that have created and perpetuated
disparities across every stage and aspect of cancer care,
from risk factors to diagnosis, treatment, and survivorship. The NCI Cancer Control Continuum (Fig. 1) provides a comprehensive framework to consider the
various goals and activities for COE.3 Convening participants shared examples of their programs to address
disparities across the Cancer Control Continuum,
which are summarized below.
Etiology and research
Cancer centers are increasingly aligning research priorities to community needs. This includes better identifying and understanding disparities by analyzing data
disaggregated by race and ethnicity as well as other demographics, conducting implementation science research to inform improvements in care and treatment

The National Cancer Institute cancer control continuum.
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for medically underserved populations, and ensuring
diversity in clinical trial participation.1
The Sidney Kimmel Cancer Center—Jefferson Health
in Philadelphia, for example, uses patient residence zip
code to anticipate risk factors for cancer that should inform care and patient education and engagement.
Maine Medical Center conducts qualitative research
with community focus groups to identify factors it
should incorporate into care delivery, such as perspectives on fatalism associated with lung cancer and community distrust of the health system.
Many cancer centers are also establishing formal
mechanisms to regularly gather community input,
and importantly, to share back research ﬁndings with
the community. For example, North Carolina’s Levine
Cancer Institute has its cancer program development
specialists communicate directly with community
members to inform its services. The University of
Hawaii gathers community input on research priorities
through processes that align with local cultures and values, and acknowledge the impact of historical trauma
through engagement with four community advisory
groups, including a Patient Advocacy Council and
Native Hawaiian Scientiﬁc Advisory Committee.
The University of Illinois Cancer Center (UICC) has
taken a different approach, creating a talent pipeline for
clinical research staff that reﬂects the diversity representative of its local community and the diversity of
skills to deliver on its tagline—‘‘bench to community.’’
Prevention
Recognizing that inequities in health outcomes are
often the result of historic structural inequities that
manifest in risk factors, cancer centers are increasingly
focusing on primary and secondary prevention and
early detection in addition to treatment.4 Research
has shown, for example, that sales of menthol cigarettes, which carry greater lung cancer risk than tobacco cigarettes, were systematically marketed to
communities of color.5 Addressing this source of inequity requires nonclinical action, including community outreach and mobilization to advance policies
that address structural factors, education, and the
community conditions that enable risk reduction
and behavioral change.
The National Outreach Network (NON) supports a
strengthening of community outreach capacity by
working through community health educators located
at NCI Cancer Centers.6 It is expected that NON community health educators, will enhance the development
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and dissemination of culturally appropriate, evidencebased cancer information to members of underserved
communities, including rural and racially and ethnically diverse populations. Over 16 of the cancer center presenters received support from NON.
An example of community outreach is Yale Cancer
Center’s robust lung cancer prevention program that
includes tobacco cessation, weight management, and
free lung cancer screening events in community venues, such as faith-based organizations. O’Neal Comprehensive Cancer Center at the University of Alabama at
Birmingham has created a regular ‘‘No Menthol Sunday’’ event to raise community awareness of the dangers of menthol cigarettes and other tobacco products
(e.g., e-cigarettes).
Cancer centers are also increasingly lending their
expertise to further the efforts of existing coalitions
and engaging in policy to reduce disparities in prevention. For example, UC Davis Comprehensive Cancer
Center has advised on regulations on ﬂavored or menthol tobacco to prevent exposure to these risk factors
in their community.
Detection and diagnosis
To mitigate disparities in the quality and timeliness of
cancer screening and diagnosis, cancer centers are
expanding screening programs and the supportive services needed to make them effective.7
MD Anderson Cancer Center, for example, collaborates with Project ECHO to build capacity of primary
care providers in rural Texas and along the TexasMexico border to increase human papillomavirus
(HPV) vaccination uptake and provide cervical cancer
screening, which can improve access particularly for
migrant Latina women who ﬁnd travel costprohibitive or too high-risk. Similarly, the Penn
Medicine’s Abramson Cancer Center works with community partners to improve the reach of its breast
cancer screening program, incorporating teletranslation services to ensure effective communication with linguistically and ethnically diverse patient
populations around diagnosis and treatment and care
decision-making.
The University of Kentucky Markey Cancer Center
uses a Proactive Ofﬁce Encounter approach to identify
increased risk factors among patients before a patient
visit and implement a tailored, evidence-based approach to cancer screening and early detection. The
Chao Family Comprehensive Cancer Center at UC
Irvine leverages culturally competent community
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navigators to increase screening of Asian American
and Latino MediCal beneﬁciaries. The UICC uses
evidence-based patient navigation to mitigate barriers
to screening access and awareness, prevent delays in
cancer care, and provide cancer education for breast,
colorectal, cervical, and lung cancer. In an effort to create large-scale change, the UCSF Helen Diller Family
Comprehensive Cancer Center serves as the backbone
organization facilitating multiple task forces to enable
collaboration with community organizations and government agencies to improve prevention and early detection across ﬁve cancer types in San Francisco.
Treatment
To reduce disparities in treatment outcomes, cancer centers are pursuing partnerships with community-based
health care organizations to streamline care pathways
and provide more holistic care.1 Dana Farber Cancer
Center, for example, has established partnerships with
local Federally Qualiﬁed Health Centers (FQHCs) and
primary care providers to support timely cancer screening and faster referrals for follow-up and resolution. The
Ralph Lauren Center for Cancer Care, now a formal entity of Memorial Sloan Kettering Cancer Center in New
York City, focuses its efforts on ‘‘in reach’’ to educate
its established network of primary care partners on
screening guidelines, and on outreach to provide social
support to cancer patients (housing, food, ﬁnancing)
that enable them to complete courses of care.
Survivorship
Survivorship factors can be substantial drivers of cancer
inequities. For example, they can result in impacts on a
survivor’s ability to maintain access to health insurance
if unable to work or travel to follow-up appointments.8
Cancer centers are increasingly cognizant of the needs
of cancer survivors, including effective clinical transition as well as support for ongoing self-care, behavior
change, education in whole person health, and maintenance. For example, the FOSTER program at the
University of New Mexico Comprehensive Cancer
Center supports effective transitions for survivors
moving from cancer center oncology care to primary
and community-based care setting in rural areas in
New Mexico.
Cross-cutting areas
COE interventions can also cut across the Cancer
Control Continuum. Project ECHO, for example, leverages its tele-mentoring and collaborative care
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model to create connections between cancer centerbased multidisciplinary specialist teams and community oncology and primary care physicians to build
local cancer care capacity, especially in rural areas,
for prevention, diagnosis, treatment, and survivorship. Likewise, the Cancer Institute of New Jersey is
building a platform to disseminate evidence-based
practices and tools to health care providers and community organizations throughout the state aimed at
increasing prevention, screening, and early detection
efforts across the most prevalent cancers.
Health Equity and COE at Four Comprehensive
Cancer Centers
COE as mandated by the NCI is just one of many ways, in
which cancer centers are increasingly working toward equitable cancer outcomes. To provide perspective on how
NCI-supported COE activities integrate with broader
health equity efforts at cancer centers, three NCIdesignated CCCs and one emerging center presented
overviews of their institutions’ commitment, governance,
programs, and challenges related to COE. For these centers, COE is a not a vertical program area, but rather an
essential cross-cutting and foundational support undergirding high-quality research and clinical care.

Ø The Dana-Farber Harvard Cancer Center (DFHCC)
serves the Greater Boston Area and embeds a
health equity approach into research and care delivery. The Center’s Ofﬁce of Cancer Equity and
Engagement functions as a coordinating structure
for a variety of DFHCC health equity and COE
programs. Despite this structure at DFHCC and
signiﬁcant local and regional multisector cancer
control efforts, low-income, immigrant, and minority populations in DFHCC’s CA continue to
experience disproportionate cancer burden.
In a major effort to address these inequities, DFHCC
conducted implementation science research to understand cancer disparities in the local population and identify barriers to access to care. DFHCC then engaged local
health system leaders and community members to codesign interventions aimed at accelerating cancer diagnosis
and linkage to care. The resulting intervention consists
of DFHCC staff embedded within a local FQHC and a
community hospital to provide education, initial cancer
screenings, streamlined referral systems between primary
care providers and oncology specialists, second opinion
and treatment plan conﬁrmation services, and multilingual nurse navigation to assist patients through screening
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and treatment protocols. These efforts have led to increased clinical trial enrollment of minority populations
and clinical quality outcomes, including decreased time
to resolution of cancer diagnoses.
While DFHCC has implemented effective COE programs, continued institutional support, ﬁnancial resources, and systems to enable collaboration between
DFHCC, FQHC partners, and local primary care providers will be needed to sustain and scale the initiative and realize its full potential impact on patient and CA outcomes.
Ø The O’Neal Comprehensive Cancer Center at the
University of Alabama at Birmingham has a
long legacy of leadership in cancer health equity
and innovating evidence-based models of care
and support for rural and low-income communities. O’Neal led the NCI-funded Deep South Network for Cancer Control and has an 11-person
COE team with members based both at the cancer center and in local communities. Its CA is the
state of Alabama—a state with one of the highest
cancer mortality rates in the country and where a
history of structural violence and systematic marginalization of populations of color has contributed to signiﬁcant racial disparities in health
outcomes and fostered distrust of health systems
in communities of color.
O’Neal works to address these challenges in its approaches to lung, breast, and prostate cancer for rural
communities and communities of color by leveraging a
network of community health advisors to reach those at
high-risk of cancer with disease information, prevention
support, cancer screening, and treatment. It also engages
a Community Advisory Board to provide input on aligning research plans with community needs and interests.
The Center’s research includes behavioral and environmental risk factors, with current studies focused on
tobacco cessation, healthy eating, and food insecurity.
O’Neal also implements health policy recommendations throughout its CA such as the NCI’s Screen to
Save initiative as well as evidence-based practices
from the American Cancer Society’s Cancer Action
Network.9 Its shared facility for clinical trial recruitment and COE has led to increased participation in
clinical trials from communities of color.
Despite strong institutional support and progress in
health equity, O’Neal remains challenged by the size
and diversity of its CA, lack of insurance among individuals in need of treatment, and maintaining COE
programs beyond dedicated grant funding.
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Ø The UC Davis Comprehensive Cancer Center
(UCD) serves 19 inland northern California
counties, the size of West Virginia, with a population of 5 million people. The area’s population
is majority-minority, with greater proportions
of Hispanics, Asian Paciﬁc Islanders, and Native
Americans than non-Hispanic whites. Within its
CA, there is a disproportionately high rate of liver
cancer mortality among Hispanic and Paciﬁc
Islander communities.
UCD’s multipronged approach focuses on prevention,
control, and improved quality of life, while incorporating
COE and research elements. UCD is engaging with the
local community to increase colorectal cancer screening
by implementing NCI’s Screen to Save program in partnership with local FQHCs and leveraging input from a
community advisory board to inform its research agenda.
UCD is also studying HPV vaccine uptake factors and is
combining population science and therapeutics in its research by securing and testing tumor tissue samples
from underrepresented racial and ethnic populations in
gastric, liver, and lung cancer to study differences in response to therapies. UCD’s research has also translated
into policy recommendations, and UCD recently held a
public forum on use of ﬂavored tobacco, which informed
policies restricting access to this carcinogen.
The success and breadth of UCD’s COE efforts
within its diverse CA are, in part, a result of the recent
NCI COE mandate, which provided support for the associate director of COE position. Importantly, this position reports directly to the cancer center director.
Despite this progress, UCD continues to ﬁnd it challenging to prioritize among COE efforts to best meet
the diverse needs within its CA.
Ø The UICC is pursuing NCI CCC designation
while deﬁning its mission as being a communityfocused cancer center. It aims to inclusively serve
its community from ‘‘bench to bedside’’ by conducting research on health inequities, integrating
services directly with the 13 FQHCs that it owns
as well as safety net hospitals, building relationships with community organizations, and improving the diversity of cancer researchers. UICC
deﬁnes its CA as ﬁve counties, including the city
of Chicago with disproportionate incidence, morbidity and mortality for cervical, colon, lung, and
prostate cancer, particularly among African American populations.
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UICC is conducting research on the impact of structural violence on physical health and is leveraging social
engagement theory to recruit local African American
men as ‘‘citizen scientists’’ to test the accuracy of cancer biomarkers. UICC is also leveraging NCI funding
to provide training for faculty and students of a local
minority-serving university and partners with local
faith, school, and community-based organizations
to increase cervical and prostate cancer screening, access, awareness, and navigation services among African American populations.
While UICC has deep leadership commitment to
community engagement and addressing health inequities, systemic barriers continue to prove challenging
and impede progress; in particular, gaps in insurance
coverage for lower income patients and poor coordination within the cancer care system to establish clear
care pathways from screening to treatment.
A Path Forward
Recent experiences have yielded lessons for how cancer
centers can effectively pursue health equity in their communities and for how the NCI can be an effective partner
in this work. Participants highlighted the COE mandate
as an effective way to raise the proﬁle of COE and health
equity within their institutions and that resourcing for
leadership positions dedicated to COE was particularly
helpful in creating change.
Participants also noted that without additional dedicated resources and structural change, sustaining and
scaling COE interventions remain difﬁcult. They highlight how the impact of COE activities on disparities
can be improved by taking a more explicit health equity
approach, addressing structural barriers, providing adequate resources, improving the quality of care by
building patient pathways, advancing relevant policies,
and ensuring effective evaluation of COE activities and
relationships.
This focused dialogue between the NCI, cancer centers, professional and patient advocacy organizations,
philanthropy, and communities enabled organizations
to share insights and effective practices, identify common challenges and provide input to inform the
NCI’s COE guidelines, cancer disparities research priorities, funding and engagement mechanisms, and
metrics to improve their impact on equitable cancer
outcomes. Continuing this dialogue as the ﬁeld
moves forward on health equity will be critical.
Even more, it can catalyze the establishment of inclusive research and care as a standard of excellence
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and enhance the quality of the science and the relevance to the cancer burden of the nation’s leading
cancer centers.
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